A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT04033445 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1064

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Placebo
DRUG: Guselkumab

Sponsor

Janssen Research & Development, LLC